2015 – 2017
- NARCAN® Nasal Spray approved by the FDA
- Changed name from Lightlake Therapeutics to Opiant Pharmaceuticals
- Licensed heroin vaccine from Walter Reed for Opioid Use Disorder
- Initiated OPNT001 Phase 2 study in Bulimia Nervosa
- Uplisted to NASDAQ